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Background/aim: Vitamin D deficiency in diabetic patients has been shown to be associated with some inflammatory markers. However,
its relationship with erythrocyte sedimentation rate (ESR) is still unknown. The aim of this study was to investigate the relationship
between vitamin D deficiency and ESR in patients with type 2 diabetes mellitus (T2DM).
Materials and methods: This cross-sectional study was conducted with 294 consecutive patients with T2DM. Serum levels of
25-hydroxyvitamin D, glycemic parameters, lipids, ESR, and C-reactive protein were measured. Patients were evaluated according to
25-hydroxyvitamin D levels as having vitamin D deficiency, vitamin D insufficiency, and vitamin D sufficiency.
Results: ESR was found to be higher in patients with vitamin D deficiency than in patients who were vitamin D-sufficient (P < 0.001),
and ESR was negatively correlated with 25-hydroxyvitamin D level (r = –0.265, P < 0.001). HbA1c and postprandial glucose levels
were higher in patients with vitamin D deficiency than vitamin D-sufficient patients (P = 0.005 and P = 0.019, respectively). In receiver
operating curve analysis, an ESR value of 14.5 mm/h had 70.1% sensitivity and 50.3% specificity for the prediction of vitamin D
deficiency.
Conclusion: The present study revealed that ESR is higher in T2DM patients with vitamin D deficiency than patients with sufficient
vitamin D. There was an inverse association between ESR and vitamin D levels. Furthermore, vitamin D deficiency was related to poor
glycemic control.
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1. Introduction
Type 2 diabetes mellitus (T2DM) may cause serious
complications such as neuropathy, retinopathy, and
nephropathy, and its prevalence is continuing to increase
globally (1). The major points in the pathophysiology
of this complex disease are impaired insulin secretion,
insulin resistance, and systemic inflammation (2). Studies
have shown that vitamin D may have an impact on all of
these pathophysiological pathways (3,4). It has been found
that vitamin D deficiency is related to increased risk of
diabetes, impaired insulin secretion, and an increase in
insulin resistance by affecting the glucose metabolism (5,6).
Furthermore, in many studies of T2DM patients, serum
25-hydroxyvitamin D (25(OH)D) levels and glycosylated
hemoglobin (HbA1c) values have been reported to be
inversely proportional (7,8).
In the pathogenesis of T2DM, it has been demonstrated
that both insulin resistance and beta cell insufficiency are
related to inflammatory factors (9,10). On the other hand,
it was found that there is alteration in levels of several
* Correspondence: tezcankaya@gmail.com
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systemic acute phase reactants in vitamin D deficiency,
such as C-reactive protein (CRP), interleukin-6 (IL-6),
and tumor necrosis factor (TNF) (11,12). There are also
data implicating vitamin D in the pathogenesis of diabetes
through antiinflammatory effects by reducing cytokines
(13,14). The erythrocyte sedimentation rate (ESR) is an
inexpensive, easily measured, and widely used marker
that demonstrates inflammation (15). In T2DM, in spite
of a known association between 25(OH)D deficiency and
some inflammatory markers, the association of vitamin
D with ESR is unclear. The aim of the present study was
to evaluate the possible association between vitamin D
deficiency and ESR in patients with T2DM.
2. Materials and methods
This was a cross-sectional study conducted in the diabetic
outpatient department of our university hospital. A total of
294 consecutive adult patients with T2DM were included
between 1 April and 30 May in this study. Exclusion
criteria were history of liver disease, chronic renal disease,
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inflammatory disease, parathyroid disease, acute and
chronic infection, hypercortisolism, anemia, cancer,
hematological diseases, malabsorption, alcoholism,
current use of vitamin D or calcium preparations, and
pregnancy or breastfeeding. Patients were also excluded if
they were using heparin or oral contraceptives that may
increase the ESR. T2DM was defined according to World
Health Organization criteria (16).
The demographic and clinical features of the patients
were recorded. Body mass index (BMI) was calculated by
dividing the weight by the square of the height ((kg/m2).
Blood samples were obtained after an overnight
fast. Serum concentrations of 25(OH)D, CRP, glucose,
creatinine, albumin, calcium, phosphate, total cholesterol,
high-density lipoprotein cholesterol, low-density
lipoprotein (LDL) cholesterol, and triglycerides were
measured using standard laboratory procedures. The
postprandial blood glucose concentration was measured
2 h after eating. HbA1c, complete blood count, and ESR
of patients were measured as well. ESR (mm/h) was
determined by the Westergren method, and 25(OH)D
concentrations were measured using the enzyme-linked
immunosorbent assay method.
Dyslipidemia was defined according to the Third
Report of the Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III) (17) and patients who
were taking lipid-lowering drugs were also accepted
as having dyslipidemia. Patients were divided into
three groups according to 25(OH)D levels as having
vitamin D deficiency (25(OH)D < 20 ng/mL), vitamin D
insufficiency (25(OH)D 20–30 ng/mL), and vitamin D
sufficiency (25(OH)D ≥ 30 ng/mL) (18). The relationship
between vitamin D deficiency and ESR was evaluated
within the groups. The study protocol was approved by
the institutional review board of our university (approval
number: 71522473/050.01.04/102), and all participants
provided informed consent before enrollment in the study.
Statistical analyses were performed with SPSS 17.0.
Continuous data with normal distribution were expressed
as mean and standard derivation (SD), whereas median
and 25th–75th percentiles were used for nonnormally
distributed variables. Comparison of each group of
patients was performed using Kruskal–Wallis and Mann–
Whitney U tests. The chi-square test was used to examine
differences between categorical variables between groups.
Spearman’s correlation coefficients were computed to
assess correlations between variables. Logistic regression
analysis was performed to identify significant independent
associates of vitamin D level. The receiver-operating
characteristic (ROC) curve was used to determine the
optimum cut-off value of ESR in the prediction of vitamin
D deficiency. P < 0.05 was considered significant.

3. Results
Of the patients included in the study, 126 (42.1%) were male
and the mean age was 56.8 ± 10.3 years. The demographic
characteristics of the study population are shown in Table
1. The median value of duration of diabetes was 7 (3–12)
years. The median levels of 25(OH)D and ESR were 20.6
(14.3–27.2) ng/mL and 17 (11–28) mm/h, respectively.
When the patients were assessed according to 25(OH)
D levels, 141 (47.9%) patients had vitamin D deficiency,
97 (32.9%) patients had vitamin D insufficiency, and 56
(19%) patients were vitamin D-sufficient (P < 0.001).
ESR was significantly higher in patients with vitamin D
deficiency than in vitamin D-sufficient patients (P < 0.001).
Furthermore, in patients with vitamin D deficiency, the
glycemic control was worse and the rate of dyslipidemia
was higher. The characteristics of patients with and without
vitamin D deficiency are presented in Table 2.
The correlations of 25(OH)D and ESR with clinical
parameters are demonstrated in Table 3. 25(OH)D level
was negatively correlated with ESR (r = –0.265, P < 0.001).
25(OH)D and glycemic parameters including fasting
glucose, postprandial glucose, and HbA1c were negatively
correlated (r = –0.133, P = 0.022; r = –0.146, P = 0.012; and
Table 1. Baseline characteristics of 294 type 2 diabetic patients.
Female, n (%)

168 (57.1)

Age, years

56.8 ± 10.3

Duration of diabetes, years

7 (3–12)

Hypertension, n (%)

175 (59.5)

Ischemic heart disease, n (%)

43 (14.6)

Dyslipidemia, n (%)

203 (69)

Smoking, n (%)

50 (17)

BMI, kg/m

31.7 ± 5.6

Weight, kg

82.2 ± 15.5

Height, m

161.4 ± 9.2

HbA1c, %

7.9 ± 2

Creatinine, mg/dL

0.8 ± 0.2

Hemoglobin, g/dL

14.1 ± 1.5

25-OH vitamin D, ng/mL

20.6 (14.3–27.2)

ESR, mm/h

17 (11–28)

CRP, mg/L

3.4 (3.4–5.7)

2

Values are presented as means ± SD or medians (25th–75th
percentiles). BMI: Body mass index, HbA1c: glycated hemoglobin,
ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
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Table 2. Characteristics of patients with type 2 diabetes mellitus according to 25-OH vitamin D level.
Vit-D deficiency
(<20 ng/mL)

Vit-D insufficiency
(20-30 ng/mL)

Vit-D sufficient
(≥30 ng/mL)

P-value

Patients, n (%)

141 (47.9)

97 (32.9)

56 (19)

<0.001

Age, years

57.8 ± 10

56.1 ± 11

55.5 ± 9.8

0.425

Female, n (%)

94 (66.7)

37 (38.1)

37 (66.1)

0.937

Duration of diabetes, years

7 (3–14)

7 (3–13.4)

6 (3–11)

0.557

Dyslipidemia, n (%)

106 (75.1)

63 (64.9)

34 (60.7)

0.044

Hypertension, n (%)

91 (64.5)

53 (54.6)

31 (55.3)

0.232

BMI, kg/m2

32.5 ± 5.5

30.5 ± 5.8

32.2 ± 5

0.787

HbA1c, %

8.4 ± 2.2

7.6 ± 2

7.4 ± 1.4

0.005

Fasting glucose, mg/dL

170 (133–233)

151 (129–200)

150 (121–195)

0.060

Postprandial glucose, mg/dL

222 (170–300)

207 (170–256)

194 (161–245)

0.019

Total cholesterol, mg/dL

211 ± 45

198 ± 48

188 ± 32

0.001

HDL cholesterol, mg/dL

41 ± 8.4

41.4 ± 10.9

42.2 ± 7.7

0.440

LDL cholesterol, mg/dL

119 ± 33

115 ± 33

106 ± 25.5

0.027

Triglyceride, mg/dL

163 (120–238)

157 (116–220)

127 (94–194)

0,007

25 (OH) vitamin D, ng/mL

14 ± 3.8

24.2 ± 2.6

40.5 ± 10.9

<0.001

Calcium, mg/dL

9.3 ± 0.4

9.2 ± 0.6

9.3 ± 0.5

0.381

Albumin, g/dL

4.3 ± 0.2

4.3 ± 0.3

4.3 ± 0.2

0.657

WBC count, ×103/µL

7.75 ± 1.99

7.49 ± 2.14

7.82 ± 1.87

0.114

CRP, mg/L

3.4 (3.4–6.5)

3.4 (3.4–5)

3.4 (3.4–5.7)

0.467

ESR, mm/h

22 (13.5–32.5)

14 (10–23)

15 (10–21)

<0.001

Values are presented as means ± SD or medians (25th–75th percentiles). Vit: Vitamin, BMI: body mass index, HbA1c: glycated
hemoglobin, HDL: high-density lipoprotein, LDL: low-density lipoprotein, WBC: white blood cell, CRP: C-reactive protein, ESR:
erythrocyte sedimentation rate.
Table 3. Correlation of 25-OH vitamin D and erythrocyte sedimentation rate with clinical and laboratory parameters in patients with
type 2 diabetes mellitus.
Variables
Age, years

25-OH vitamin D (ng/mL)

ESR (mm/h)

r

P-value

R

P-value

–0.086

0.141

0.266

<0.001

Duration of diabetes, years

–0.079

0.177

0.174

0.003

BMI, kg/m2

–0.137

0.018

0.262

<0.001

Fasting glucose, mg/dL

–0.133

0.022

0.017

0.775

Postprandial glucose, mg/dL

–0.146

0.012

0.000

0.993

HbA1c, %

–0.166

0.004

0.057

0.337

Total cholesterol, mg/dL

–0.192

0.001

0.075

0.202

LDL, mg/dL

–0.137

0.019

0.036

0.548

Triglyceride, mg/dL

–0.123

0.035

0.102

0.085

25-OH vitamin D, ng/mL

-

-

–0.265

<0.001

ESR, mm/h

–0.265

<0.001

-

-

CRP, mg/L

–0.002

0.969

0.324

<0.001

0.030

0.610

0.122

0.037

WBC count, ×10 /µL
3

ESR: Erythrocyte sedimentation rate, BMI: body mass index, HbA1c: glycated hemoglobin, LDL: low-density lipoprotein, CRP:
C-reactive protein, WBC: white blood cell.

426

KAYA et al. / Turk J Med Sci
r = –0.166, P = 0.004, respectively). Moreover, there was a
negative correlation between 25(OH)D and lipid parameters
such as total cholesterol, LDL cholesterol, and triglyceride
(r = –0.192, P = 0.001; r = –0.137, P = 0.019; r = –0.123, P =
0.035, respectively). Multivariate logistic regression analysis
of clinical and laboratory predictors for vitamin D level
revealed that ESR and HbA1c were significant independent
predictors (OR = –0.205, 95% CI = –0.282 to –0.076, P =
0.001 and OR = –0.131, 95% CI = –1.380 to –0.085, P =
0.027, respectively). ROC curve analysis suggested that
the optimum ESR cut-off point for the development of
vitamin D deficiency was 14.5 mm/h, with a sensitivity and
specificity of 70.1% and 50.3%, respectively (area under the
curve = 0.659, P < 0.001) (Figure).
4. Discussion
This study demonstrates that patients with T2DM who
were vitamin D-deficient had higher ESR, poor glycemic
control, and a greater prevalence of dyslipidemia.

Additionally, in the present study, we found a negative
correlation between 25(OH)D level and both ESR and
glycemic parameters, i.e. fasting glucose, postprandial
glucose, and HbA1c.
The pathophysiology of T2DM is complex and several
different interrelated mechanisms are involved, which
are still not precisely understood (2). Accruing evidence
has shown that vitamin D deficiency and inflammation
play important roles in this chronic process through
several pathways (19,20). Some previous studies have
demonstrated that vitamin D deficiency is related to
insulin resistance, impaired insulin secretion, and T2DM
development (3,5,7). Furthermore, similar to our results,
earlier studies reported that there is an inverse correlation
between plasma 25(OH)D level and blood glucose in
T2DM patients (7,8).
There are various data regarding how vitamin D affects
glucose metabolism in patients with diabetes (3,21). In
some studies, it has been demonstrated that there are

Figure. Receiver operator characteristic curve analysis of erythrocyte sedimentation rate for
vitamin D deficiency.
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vitamin D receptors in pancreatic beta cells, liver, skeletal
muscles, and adipose tissue, and that vitamin D affects
insulin synthesis, secretion, and sensitivity through these
receptors (3,22,23). In support of this relationship, Bland
et al. noted that pancreatic beta cells also possess the
1-alpha-hydroxylase enzyme that converts 25(OH)D to
its active form (24). It has been suggested that vitamin D
can be effective on insulin metabolism by stimulating the
insulin receptors in peripheral tissues, which is important
for insulin resistance and adjusting intracellular cytosolic
calcium (3,19). Calcium is needed for insulin to act on
target tissues (3,19). Calcium depletion in these tissues
secondary to vitamin D deficiency can lead to peripheral
insulin resistance (19). On the other hand, it has been
reported in some studies that the decrease in insulin
sensitivity in vitamin D deficiency can be due to increased
parathyroid hormone secretion (3,19).
The available data demonstrate that in the
pathophysiology of T2DM systemic inflammation is one
of the important factors of beta cell dysfunction, beta
cell apoptosis, and development of insulin resistance in
peripheral tissues (9,10). There are conflicting results
about whether there is a positive relationship between
vitamin D deficiency and some inflammatory markers
or not (11–14). In some studies, an increase in some
inflammation markers such as TNF, CRP, IL-6, and
IL-8 has been observed in T2DM (9,10). In our study,
we demonstrated for the first time that ESR is higher in
patients with vitamin D deficiency. With regard to vitamin
D and inflammation interaction, it has been postulated that
vitamin D may increase insulin resistance by decreasing
some inflammatory cytokines and stimulating the glucose
transport (3,19,21). Moreover, Giulietti et al. reported a
decrease in some inflammatory cytokines such as TNFalpha, IL-1, IL-6, and IL-8 after administration of vitamin
D (25).
In the present study we found higher levels of
total cholesterol, LDL cholesterol, and triglycerides in
patients with vitamin D deficiency. In addition, there
was an inverse correlation between serum 25(OH)D and
lipid parameters and BMI. Dyslipidemia is one of the
most important factors for cardiovascular disease and
a common cause of morbidity and mortality in diabetic
patients (26). Hyperglycemia and dyslipidemia may affect

each other causally (27). Furthermore, similar to our
study, low 25(OH)D levels were associated with obesity
and dyslipidemia in previous studies (27,28). There
are data demonstrating that vitamin D deficiency may
influence dyslipidemia through various mechanisms such
as insulin secretion, lipotoxicity, gastrointestinal calcium
absorption, inflammation, and increase in the parathyroid
hormone level (27). However, the pathophysiology of
diabetic dyslipidemia is yet to be fully understood (27).
The present study revealed that ESR was positively
correlated with age, duration of diabetes, and BMI. In
addition, ESR was positively correlated with inflammation
markers such as CRP and white blood cell count. ESR is
a simple and cheap laboratory test used as a nonspecific
indicator of acute phase response (15). It has been
demonstrated that ESR increases with age every 5 years by
0.85 mm/h; however, the reason for this increase is unclear
(15). At the same time, an increase in ESR with obesity
has been reported in previous studies (15). Similar to our
study, Colombet et al. reported that there is a positive
relationship between simultaneously measured ESR and
CRP (29). Analyses of the First National Health and
Nutrition Examination Survey Epidemiologic Follow-up
Study (NHANES I) data have demonstrated that ESR is a
predictor for the risk of coronary heart disease and stroke
incidence among a subset of adults (30,31). However, there
are sparse data about the relationship of ESR with diabetes
and vitamin D level.
Our study has some limitations. First, our research
included a relatively small sample size and study patients
were from only our country. Second, the research design
of current study was cross-sectional. An interventional
research study including the comparison of pretreatment
and posttreatment vitamin D could be designed.
In conclusion, our study revealed that ESR is higher
in vitamin D-deficient T2DM patients than those with
sufficient vitamin D levels, and there is an inverse correlation
between ESR and vitamin D levels. Furthermore, in the
present study, vitamin D-deficient patients had poor
glycemic control and higher levels of total cholesterol,
LDL cholesterol, and triglycerides. Further studies may
expand our understanding of how inflammation, vitamin
D, glycemic control, and dyslipidemia interact in patients
with T2DM.
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